Anti-HIV Type 1 Properties of Chemically Modified Heparins with Diminished Anticoagulant Activity
Lucia Lopalco(Vita-Salute San Raffaele University), Antonio G. Siccardi(San Raffaele University of Rome), Franca Ciccomascolo, Paola Lanza(Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia), Alberto Beretta, G Zoppetti(Vita-Salute San Raffaele University), Flavio Leoni(Vita-Salute San Raffaele University), I. Caramazza(Vita-Salute San Raffaele University)
Cited by 21
Related Papers
In vivo evolution of HIV-1 co-receptor usage and sensitivity to chemokine-mediated suppression
|Nature Medicine|1997|635
Control of HIV despite the Discontinuation of Antiretroviral Therapy
|New England Journal of Medicine|1999|328
Immunization with HIV-1 gp41 Subunit Virosomes Induces Mucosal Antibodies Protecting Nonhuman Primates against Vaginal SHIV Challenges
|Immunity|2011|285
Three-step monoclonal antibody tumor targeting in carcinoembryonic antigen-positive patients.
|PubMed|1991|247
Mucosal and Plasma IgA from HIV-1-Exposed Uninfected Individuals Inhibit HIV-1 Transcytosis Across Human Epithelial Cells
|The Journal of Immunology|2000|244